中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2014年
24期
93-95
,共3页
脑心通胶囊%急性脑梗死%效果观察
腦心通膠囊%急性腦梗死%效果觀察
뇌심통효낭%급성뇌경사%효과관찰
Naoxintong capsule%Acute cerebral infarction%Effect observation
目的：探讨脑心通胶囊治疗急性脑梗死的临床效果。方法选择228例急性脑梗死患者作为研究对象，均为本院2011年1月~2014年1月收治，将患者按治疗方法分组，就常规西药治疗(对照组，n=100)与加用脑心通胶囊(观察组，n=128)的效果进行比较。结果观察组的总有效率为85.9%，明显高于对照组的65.0%(P<0.05)。两组治疗前的CSS评分比较，差异无统计学意义(P>0.05)，两组治疗后的CSS评分均较治疗前降低(P<0.05)，且观察组降低更明显(P<0.05)。两组治疗前的血液流变学各项指标比较，差异无统计学意义(P>0.05)，治疗后，两组的上述各指标均有所改善(P<0.05)，观察组的改善情况优于对照组(P<0.05)。观察组治疗期间有胃肠道反应4例，对照组3例，对治疗未造成影响，无其他严重不良反应发生。结论急性脑梗死采用脑心通胶囊治疗，可显著增强临床效果，改善症状和预后，确保提高患者的生活质量，具有非常重要的应用价值，值得临床广泛推广。
目的：探討腦心通膠囊治療急性腦梗死的臨床效果。方法選擇228例急性腦梗死患者作為研究對象，均為本院2011年1月~2014年1月收治，將患者按治療方法分組，就常規西藥治療(對照組，n=100)與加用腦心通膠囊(觀察組，n=128)的效果進行比較。結果觀察組的總有效率為85.9%，明顯高于對照組的65.0%(P<0.05)。兩組治療前的CSS評分比較，差異無統計學意義(P>0.05)，兩組治療後的CSS評分均較治療前降低(P<0.05)，且觀察組降低更明顯(P<0.05)。兩組治療前的血液流變學各項指標比較，差異無統計學意義(P>0.05)，治療後，兩組的上述各指標均有所改善(P<0.05)，觀察組的改善情況優于對照組(P<0.05)。觀察組治療期間有胃腸道反應4例，對照組3例，對治療未造成影響，無其他嚴重不良反應髮生。結論急性腦梗死採用腦心通膠囊治療，可顯著增彊臨床效果，改善癥狀和預後，確保提高患者的生活質量，具有非常重要的應用價值，值得臨床廣汎推廣。
목적：탐토뇌심통효낭치료급성뇌경사적림상효과。방법선택228례급성뇌경사환자작위연구대상，균위본원2011년1월~2014년1월수치，장환자안치료방법분조，취상규서약치료(대조조，n=100)여가용뇌심통효낭(관찰조，n=128)적효과진행비교。결과관찰조적총유효솔위85.9%，명현고우대조조적65.0%(P<0.05)。량조치료전적CSS평분비교，차이무통계학의의(P>0.05)，량조치료후적CSS평분균교치료전강저(P<0.05)，차관찰조강저경명현(P<0.05)。량조치료전적혈액류변학각항지표비교，차이무통계학의의(P>0.05)，치료후，량조적상술각지표균유소개선(P<0.05)，관찰조적개선정황우우대조조(P<0.05)。관찰조치료기간유위장도반응4례，대조조3례，대치료미조성영향，무기타엄중불량반응발생。결론급성뇌경사채용뇌심통효낭치료，가현저증강림상효과，개선증상화예후，학보제고환자적생활질량，구유비상중요적응용개치，치득림상엄범추엄。
Objective To investigate the clinical effect of Naoxintong capsule treating acute cerebral infarction. Meth-ods 228 patients with acute cerebral infarction treated in our hospital from January 2011 to January 2014 were selected for the study and they were randomly divided into the two groups according to the treatment method.The control group was given conventional western medicine (n=100) while the observation group was given Naoxintong capsule on the ba-sis of the control group (n=128),the effect of the two groups was compared. Results The total effective rate in the ob-servation group (85.9%) was obviously higher than that in the control group (65.0%) (P<0.05).There was no statistical difference of CSS score in the two groups before treatment (P>0.05),after treatment,CSS score in the two groups were decreased compared with before treatment (P<0.05) and the observation group decreased obvioluly (P<0.05).There was no statistical difference of hemorheology indexes of the two groups before treatment (P>0.05),after treatment,above-men-tioned indexes in the two groups were improved (P<0.05),the observation group improved better than the control group (P<0.05).During treatment,there were 4 cases of gastrointestinal reaction in the observation group and 3 cases in the control group,and these did not impact treatment,there was no other serious adverse reactions. Conclusion Naoxintong capsule treating acute cerebral infarction can significantly enhance the clinical effect,improve symptoms and the prog-nosis to ensure improve quality of life of patients with a very important value,and it is worthy of clinical widely promo-tion.
